The Exchange has sought clarification from Granules India Limited with respect to recent news item captioned Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices. The response from the Company is awaited.
GRANULES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than Nifty Smallcap 250 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The NSE has asked Granules India to clarify a recent news article titled 'Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices.' The company has not yet responded. This appears to be a routine exchange query triggered by a media report, not an action against the company. Granules India is an Indian pharmaceutical manufacturer with significant US exposure, which is why it was named in this sector-wide news. Investors should wait for the company's official response to understand any direct impact.
Short-term: No direct impact on the stock or shareholders, as this is just an exchange clarification request, not a regulatory action. Watch for the company's response to confirm or deny any material exposure to Trump's pricing push.